Man Group plc Sells 86,438 Shares of Humana Inc. (NYSE:HUM)

Man Group plc lowered its position in shares of Humana Inc. (NYSE:HUM - Free Report) by 85.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,283 shares of the insurance provider's stock after selling 86,438 shares during the quarter. Man Group plc's holdings in Humana were worth $3,624,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. FPC Investment Advisory Inc. acquired a new stake in Humana during the 4th quarter valued at $27,000. Centricity Wealth Management LLC purchased a new position in shares of Humana during the fourth quarter valued at $30,000. LFA Lugano Financial Advisors SA raised its position in Humana by 56.3% during the fourth quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock valued at $32,000 after buying an additional 45 shares during the period. OFI Invest Asset Management purchased a new stake in Humana in the 4th quarter worth about $33,000. Finally, Transce3nd LLC purchased a new stake in Humana in the 4th quarter worth about $38,000. Hedge funds and other institutional investors own 92.38% of the company's stock.

Humana Stock Performance

NYSE:HUM traded up $0.38 during trading hours on Tuesday, hitting $225.31. 253,035 shares of the company traded hands, compared to its average volume of 1,774,698. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. Humana Inc. has a twelve month low of $212.45 and a twelve month high of $406.46. The firm has a 50-day moving average of $260.33 and a 200 day moving average of $268.05. The stock has a market capitalization of $27.19 billion, a price-to-earnings ratio of 22.59, a P/E/G ratio of 2.05 and a beta of 0.49.

Humana (NYSE:HUM - Get Free Report) last released its earnings results on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share for the quarter, topping analysts' consensus estimates of $10.07 by $1.51. Humana had a return on equity of 11.70% and a net margin of 1.02%. The business had revenue of $32.11 billion for the quarter, compared to the consensus estimate of $32 billion. During the same period last year, the business earned $7.23 earnings per share. The firm's revenue for the quarter was up 8.4% compared to the same quarter last year. On average, analysts forecast that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.57%. The ex-dividend date of this dividend is Friday, June 27th. Humana's dividend payout ratio is 25.04%.

Analysts Set New Price Targets

Several equities analysts have weighed in on HUM shares. Robert W. Baird lifted their target price on Humana from $270.00 to $300.00 and gave the company a "neutral" rating in a research note on Tuesday, April 15th. Oppenheimer boosted their price objective on shares of Humana from $300.00 to $310.00 and gave the company an "outperform" rating in a research report on Thursday, May 1st. JPMorgan Chase & Co. dropped their price objective on shares of Humana from $257.00 to $256.00 and set a "neutral" rating on the stock in a research note on Tuesday, February 18th. Raymond James raised shares of Humana from a "market perform" rating to an "outperform" rating and set a $315.00 target price for the company in a research note on Thursday, May 1st. Finally, Barclays upped their price target on shares of Humana from $270.00 to $322.00 and gave the stock an "equal weight" rating in a research note on Friday, April 11th. Seventeen equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $286.81.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.